|
Novelion Therapeutics, Inc.
Ticker Symbol: NVLNF* CUSIP: 67001K103 Previous CUSIP: 67001K103 Exchange: OTOTC
* NOTE: This security is no longer trading as of 1/16/2020
Company's Online Profile
BUSINESS: Novelion Therapeutics, Inc. is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc.
|
Notes: January 09 2020 -- The Company announced that the Supreme Court of British Columbia (the “Court”) has granted the orders sought by the Company in connection with the Liquidation. The Company will file a Statement of Intent to Liquidate with the British Columbia Registrar of Companies establishing the definitive effective date and time for the commencement of implementation of the Liquidation as 5:00 p.m. Pacific Time on January 16, 2020 (the “Effective Date”). ________________ December 16, 2016 -- Novelion Therapeutics Inc. (NVLN) will effect a one-for-five (1-5) reverse split of its common shares. The CUSIP number will change to 67001K202 effective 12/19/2016._______________November 2016, Novelion was launched through a merger transaction in which Aegerion Pharmaceuticals became an indirect, wholly-owned subsidiary of QLT Inc. In conjunction with the closing of the merger, QLT changed its name to Novelion Therapeutics Inc._____________Nov. 15, 2016 -- The previously announced merger between QLT Inc. (QLTI) and Aegerion Pharmaceuticals, Inc. (AEGR) is expected to become effective on Tuesday, November 29, 2016. As a result, Aegerion Pharmaceuticals, Inc. (AEGR) is expected to be suspended from trading effective November 30, 2016. As a result of the merger, QLT Inc. (QLTI) will be the surviving entity and will have a name change to Novelion Therapeutics Inc.with a new symbol NVLN. New cusip will be 67001K103
|
Previous Ticker Symbol: NVLN Changed: 10/09/2019
Previous Name: QLT, Inc. Changed: 11/30/2016
Small Cap Stock -
Market Value $162.0 Million
|
Company's Online Information Links
|
| Company's Online Government Filings Links |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 887 Great Northern Way, Suite 250, Vancouver, B.C. Canada, V5T 4T5 |
| Main Phone Number |
604-707-7000 |
| Fax Number |
604-707-7001 |
| Investor Relations
|
877-764-3131
|
| Toll Free Phone Number |
877-764-3131 |
| CEO - Mary Szela |
CFO - Gregory Perry |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
